These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6373161)

  • 1. Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice.
    Allsopp LF; Cooper GL; Poole PH
    Curr Med Res Opin; 1984; 9(1):64-70. PubMed ID: 6373161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An uncontrolled trial of clomipramine (Anafranil) in the treatment of phobic and obsessional states in general practice.
    Gringras M
    J Int Med Res; 1977; 5 Suppl 5():111-5. PubMed ID: 598599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness.
    Waxman D
    J Int Med Res; 1977; 5 Suppl 5():99-110. PubMed ID: 598611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large open multicentre trial of clomipramine (Anafranil) in the management of phobic disorders.
    Beaumont G
    J Int Med Res; 1977; 5 Suppl 5():116-23. PubMed ID: 598600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of sustained-release clomipramine (Anafranil SR) in the treatment of phobias: a comparison with the conventional formulation of clomipramine (Anafranil).
    Allsopp LF; Huitson A; Deering RB; Brodie NH
    J Int Med Res; 1985; 13(4):203-8. PubMed ID: 3899771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R; Berchou R; Rainey JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomipramine treatment of agoraphobic women. An eight-week controlled trial.
    Johnston DG; Troyer IE; Whitsett SF
    Arch Gen Psychiatry; 1988 May; 45(5):453-9. PubMed ID: 3282481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and of its combinations with haloperidol and diazepam.
    Cassano GB; Castrogiovanni P; Mauri M; Rutigliano G; Pirro R; Cerone G; Nielsen NP; Reitano S; Guidotti N; Bedarida D; Marchetti FP; Catalano A; Benecchi MV; Amabile G; Zanasi M; Pugliese L; Rocco ML; Balestrieri A; Tansella M; Burti L; Pariante F
    Prog Neuropsychopharmacol; 1981; 5(2):129-38. PubMed ID: 7022513
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia.
    Ghoneim MM; Hinrichs JV; Noyes R; Anderson DJ
    Neuropsychobiology; 1984; 11(4):229-35. PubMed ID: 6387529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does tryptophan potentiate clomipramine in the treatment of agoraphobic and social phobic patients?
    Pecknold JC; McClure DJ; Appeltauer L; Allan T; Wrzesinski L
    Br J Psychiatry; 1982 May; 140():484-90. PubMed ID: 7049293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind controlled study in phobias and obsessions.
    Karabanow O
    J Int Med Res; 1977; 5 Suppl 5():42-8. PubMed ID: 340306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
    Mountjoy CQ; Roth M; Garside RF; Leitch IM
    Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the use of anafranil in phobic and obsessional disorders.
    Waxman D
    Scott Med J; 1975; 20(1 SUPPL):61-6. PubMed ID: 1154017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study.
    Savoldi F; Somenzini G; Ecari U
    Curr Med Res Opin; 1990; 12(3):185-90. PubMed ID: 2272192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. School phobia: a therapeutic trial with clomipramine and short-term outcome.
    Berney T; Kolvin I; Bhate SR; Garside RF; Jeans J; Kay B; Scarth L
    Br J Psychiatry; 1981 Feb; 138():110-8. PubMed ID: 7020816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant medication in the treatment of agoraphobia: a critical review.
    Telch MJ; Tearnan BH; Taylor CB
    Behav Res Ther; 1983; 21(5):505-17. PubMed ID: 6140001
    [No Abstract]   [Full Text] [Related]  

  • 19. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
    Modigh K; Westberg P; Eriksson E
    J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
    den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
    Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.